Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TEVA - Endo: A Win In California But Equity Value Still A Question


TEVA - Endo: A Win In California But Equity Value Still A Question

  • California State Court hands Endo and other opioid producers a temporary win in liability trial.
  • Tentative ruling directs manufacturers to file a statement of decision within 30 days.
  • Ruling likely takes away major liability in the country's biggest state at least for a while.
  • Leverage remains too high, particularly with Vasostrict EBITDA at risk.
  • Bankruptcy is now likely off the table but struggle to see equity value.

For further details see:

Endo: A Win In California But Equity Value Still A Question
Stock Information

Company Name: Teva Pharmaceutical Industries Limited American Depositary Shares
Stock Symbol: TEVA
Market: NYSE
Website: tevapharm.com

Menu

TEVA TEVA Quote TEVA Short TEVA News TEVA Articles TEVA Message Board
Get TEVA Alerts

News, Short Squeeze, Breakout and More Instantly...